13F reference period
Q2 2026
Security Snapshot
Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT) Institutional Ownership
CUSIP: 359664109
13F Institutional Holders and Ownership History from Q3 2016 to Q3 2026
Institutions Reporting
140
Shares (Excl. Options)
15.69M
Full value: 15,688,736 · shares · 30 Jun 2026Price
$20.52
The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Symbol
- FLGT on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 15,688,736
- Total 13F value
- $321,831,694
- Portfolio coverage rank
- 0%
- Share change
- -1,807,782
- Value change
- -$28,308,619
- Number of holders
- 140
- Shares outstanding
- 27,503,221
- SEC-reported price per share
- $22.02
- Insider filing price
- $22.02
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- FLGT - Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share is tracked under CUSIP 359664109.
- 140 institutions reported positions in Q2 2026.
- 4 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 156 to 140 between Q1 2026 and Q2 2026.
- SEC-reported value moved from to
$277.27M
Full value: $277,268,819 · USD · 31 Mar 2026.$321.83M
Full value: $321,831,694 · USD · 30 Jun 2026
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 140 institutions filings for Q2 2026.
Security key
359664109
13F reference period
Q2 2026
13F holders
140
13D/G owners
4
CIK / CUSIP context first
Open Q2 2026 holders
FLGT full holder history
Fulgent Genetics, Inc. SEC filings
Fulgent Genetics, Inc. company facts
Fulgent Genetics, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 359664109:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
4
Security
FLGT
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Hsieh Ming | 32% | +4.9% | $138,411,608 | +$81,682 | 8,872,539 | +0.06% | Ming Hsieh | 22 May 2026 |
| BARCLAYS PLC | 7.6% | +43% | $42,396,117 | +$12,335,507 | 2,338,451 | +41% | Barclays PLC | 31 Mar 2025 |
| BlackRock, Inc. | 5.9% | $32,993,391 | 1,819,823 | BlackRock, Inc. | 31 Mar 2025 | |||
| MILLENNIUM MANAGEMENT LLC | 3% | -43% | $24,677,381 | -$19,766,494 | 939,375 | -44% | Millennium Management LLC | 31 Dec 2025 |
As of 30 Jun 2026,
140
institutional investors reported holding
shares of
Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT).
This represents
57%
of the company’s total
outstanding shares.
15.69M
Full value: 15,688,736 · shares · 30 Jun 202627.5M
Full value: 27,503,221 · shares · Stored outstanding share count13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
46%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 8.3% | 2,286,669 | -18% | 0% | $46,922,448 |
| ACADIAN ASSET MANAGEMENT LLC | 3.7% | 1,017,913 | -18% | 0.02% | $20,873,000 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.9% | 789,498 | -10% | 0% | $16,200,499 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 2.8% | 782,116 | +119% | 0.06% | $16,049,020 |
| JPMORGAN CHASE & CO | 2.8% | 756,558 | +64% | 0% | $15,532,135 |
| Diametric Capital, LP | 2.5% | 697,784 | +93% | 1.5% | $14,318,527 |
| AMERIPRISE FINANCIAL INC | 2.4% | 670,084 | +19% | 0% | $13,750,124 |
| DIMENSIONAL FUND ADVISORS LP | 2.3% | 625,355 | -6.9% | 0% | $12,832,302 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.9% | 521,014 | -11% | 0% | $10,693,721 |
| STATE STREET CORP | 1.8% | 498,673 | -5.8% | 0% | $10,232,770 |
| Invenomic Capital Management LP | 1.8% | 498,287 | -18% | 0.61% | $10,224,849 |
| TWO SIGMA INVESTMENTS, LP | 1.5% | 400,986 | +24% | 0.01% | $8,228,233 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.3% | 350,987 | -0.9% | 0% | $7,202,253 |
| MILLENNIUM MANAGEMENT LLC | 1.2% | 320,910 | -20% | 0% | $6,585,073 |
| GOLDMAN SACHS GROUP INC | 1.1% | 307,940 | -1.1% | 0% | $6,318,929 |
| D. E. Shaw & Co., Inc. | 1.1% | 292,006 | -40% | 0% | $5,991,963 |
| HRT FINANCIAL LP | 0.83% | 229,444 | +394% | 0.01% | $4,708,000 |
| Peapod Lane Capital LLC | 0.82% | 224,207 | +1.6% | 3.1% | $4,600,728 |
| Point72 Asset Management, L.P. | 0.77% | 211,708 | 0.01% | $4,344,248 | |
| Medina Value Partners, LLC | 0.7% | 193,061 | +14% | 0.78% | $3,961,612 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 0.68% | 186,311 | -14% | 0% | $3,823,102 |
| BANK OF AMERICA CORP /DE/ | 0.64% | 175,581 | +46% | 0% | $3,602,922 |
| UBS Group AG | 0.64% | 174,952 | -27% | 0% | $3,590,015 |
| CITADEL ADVISORS LLC | 0.63% | 174,180 | +229% | 0% | $3,574,174 |
| NORTHERN TRUST CORP | 0.62% | 170,018 | -6.6% | 0% | $3,488,769 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
41
Headline period
Q2 2026
Rows shown
1-25 of 41
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q3 | 343,001 | $7,552,703 | -$1,535,687 | $22.02 | 21 |
| 2026 Q2 | 15,688,736 | $321,831,694 | -$28,308,619 | $20.52 | 140 |
| 2026 Q1 | 17,449,202 | $277,268,819 | -$17,907,084 | $15.90 | 156 |
| 2025 Q4 | 17,853,481 | $468,977,899 | +$23,698,644 | $26.27 | 180 |
| 2025 Q3 | 17,228,150 | $389,319,933 | +$21,532,182 | $22.60 | 163 |
| 2025 Q2 | 16,260,263 | $323,227,753 | +$1,152,439 | $19.88 | 165 |
| 2025 Q1 | 16,317,307 | $275,768,406 | -$14,217,098 | $16.90 | 173 |
| 2024 Q4 | 17,016,195 | $314,285,279 | +$12,985,883 | $18.47 | 185 |
| 2024 Q3 | 16,092,056 | $349,642,907 | +$18,556,959 | $21.73 | 181 |
| 2024 Q2 | 15,271,785 | $299,655,107 | +$9,367,412 | $19.62 | 170 |
| 2024 Q1 | 14,727,786 | $319,564,135 | +$6,539,138 | $21.70 | 177 |
| 2023 Q4 | 14,302,809 | $413,495,913 | +$4,547,542 | $28.91 | 193 |
| 2023 Q3 | 14,229,204 | $380,479,266 | +$6,537,668 | $26.74 | 196 |
| 2023 Q2 | 13,900,018 | $514,629,091 | +$13,570,378 | $37.03 | 210 |
| 2023 Q1 | 13,537,003 | $422,618,519 | +$14,324,645 | $31.22 | 213 |
| 2022 Q4 | 13,130,080 | $391,069,830 | -$9,588,373 | $29.78 | 218 |
| 2022 Q3 | 13,298,290 | $506,859,271 | -$7,820,533 | $38.12 | 217 |
| 2022 Q2 | 12,997,411 | $708,963,224 | +$53,955,153 | $54.53 | 247 |
| 2022 Q1 | 12,047,292 | $751,600,750 | +$40,161,746 | $62.41 | 263 |
| 2021 Q4 | 11,205,792 | $1,127,293,672 | -$26,292,784 | $100.59 | 284 |
| 2021 Q3 | 11,367,430 | $1,022,253,660 | +$64,809,061 | $89.95 | 258 |
| 2021 Q2 | 10,632,791 | $980,578,944 | +$54,311,867 | $92.23 | 246 |
| 2021 Q1 | 10,008,047 | $966,031,706 | +$64,885,192 | $96.62 | 243 |
| 2020 Q4 | 9,615,937 | $501,565,082 | +$82,198,208 | $52.10 | 184 |
| 2020 Q3 | 8,084,326 | $323,850,761 | +$79,786,110 | $40.04 | 122 |